Burlington Stores Inc
Change company Symbol lookup
Select an option...
BURL Burlington Stores Inc
TNEN True North Energy Corp
H Hyatt Hotels Corp
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
ORC Orchid Island Capital Inc
GBX Greenbrier Companies Inc
Go

Consumer Discretionary : Specialty Retail | Mid Cap Blend
Company profile

Burlington Stores, Inc. is a retailer of branded apparel. The Company operates approximately 866 retail stores in approximately 45 states and Puerto Rico. It sells in-season, fashion-focused merchandise, including women’s ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. The Company operates five distribution centers. Its two east coast distribution centers are located in Edgewater Park, New Jersey and Burlington, New Jersey and three west coast distribution centers are located in San Bernardino, California, Redlands, California, and Riverside, California. It also operates warehousing facilities to support its distribution centers. The Company uses a mix of broad-based and targeted marketing strategies. Its broad-based strategies include national and local television and radio. Its digital and streaming audio strategies include personalized and targeted messaging.

Postmarket

Last Trade
Delayed
$156.83
-0.16 (-0.10%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$156.99
Day's Change
2.99 (1.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
160.24
Day's Low
156.78
Volume
(Light)
Volume:
664,945

10-day average volume:
917,487
664,945

Finch Therapeutics to Participate in Upcoming June Investor Conferences

7:00 am ET June 2, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:FNCH), EQNX::TICKER_END Finch Therapeutics Group, Inc. ("Finch" or "Finch Therapeutics") (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs, today announced that Mark Smith, PhD, Chief Executive Officer, will participate in fireside chats at the following investor conferences:

-- JMP Securities Life Sciences Conference on Wednesday, June 15, 2022 at 2:00 pm ET in New York, NY

Live webcasts of the fireside chats will be available under the "Investors & News" section of the Finch website and will be archived for approximately 30 days following each event.

About Finch Therapeutics

Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery(R) platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted microbiome therapeutics, Finch is advancing a rich pipeline of candidates designed to address a wide range of unmet medical needs. Finch's lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. Finch is also developing FIN-211 for children with autism spectrum disorder and significant gastrointestinal symptoms. Finch has a partnership with Takeda focused on the development of targeted microbiome therapeutics for inflammatory bowel disease. Finch routinely posts information that may be important to its investors on its website at www.finchtherapeutics.com. Finch encourages investors to consult the "Investors & News" section of its website regularly.

Human-First Discovery is a registered trademark of Finch Therapeutics Group, Inc.

Investor Contact:

Stephen Jasper

Gilmartin Group

(858) 525-2047

stephen@gilmartinir.com

Media Contact:

Jenna Urban

Berry & Company Public Relations

(212) 253-8881

jurban@berrypr.com

https://ml.globenewswire.com/media/ed11f446-5d40-40a6-b924-330716eebebd/small/finch-short-logo-l-png.png

https://ml.globenewswire.com/media/ed11f446-5d40-40a6-b924-330716eebebd/small/finch-short-logo-l-png.png

comtex tracking

COMTEX_408095630/2010/2022-06-02T07:00:01

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.